[go: up one dir, main page]

EP1931387A4 - PHARMACEUTICAL FORMULATIONS OF BIODEGRADABLE MICROPARTICLES HAVING IMPROVED RELEASE RATES - Google Patents

PHARMACEUTICAL FORMULATIONS OF BIODEGRADABLE MICROPARTICLES HAVING IMPROVED RELEASE RATES

Info

Publication number
EP1931387A4
EP1931387A4 EP06803043A EP06803043A EP1931387A4 EP 1931387 A4 EP1931387 A4 EP 1931387A4 EP 06803043 A EP06803043 A EP 06803043A EP 06803043 A EP06803043 A EP 06803043A EP 1931387 A4 EP1931387 A4 EP 1931387A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical formulations
release rates
improved release
biodegradable microparticles
microparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06803043A
Other languages
German (de)
French (fr)
Other versions
EP1931387A2 (en
Inventor
Eliot M Slovin
Joseph T Persyn
Joseph A Mcdonough
Neal K Vail
Darren E Barlow
Albert M Zwiener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest Research Institute SwRI
Original Assignee
Southwest Research Institute SwRI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/220,430 external-priority patent/US7758778B2/en
Priority claimed from US11/221,337 external-priority patent/US7261529B2/en
Priority claimed from US11/220,807 external-priority patent/US9693967B2/en
Application filed by Southwest Research Institute SwRI filed Critical Southwest Research Institute SwRI
Publication of EP1931387A2 publication Critical patent/EP1931387A2/en
Publication of EP1931387A4 publication Critical patent/EP1931387A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
EP06803043A 2005-09-07 2006-09-06 PHARMACEUTICAL FORMULATIONS OF BIODEGRADABLE MICROPARTICLES HAVING IMPROVED RELEASE RATES Withdrawn EP1931387A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US22044505A 2005-09-07 2005-09-07
US22043105A 2005-09-07 2005-09-07
US11/220,430 US7758778B2 (en) 2005-09-07 2005-09-07 Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents
US11/221,337 US7261529B2 (en) 2005-09-07 2005-09-07 Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
US11/220,807 US9693967B2 (en) 2005-09-07 2005-09-07 Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
PCT/US2006/034722 WO2007030545A2 (en) 2005-09-07 2006-09-06 Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates

Publications (2)

Publication Number Publication Date
EP1931387A2 EP1931387A2 (en) 2008-06-18
EP1931387A4 true EP1931387A4 (en) 2012-07-11

Family

ID=37836422

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06803043A Withdrawn EP1931387A4 (en) 2005-09-07 2006-09-06 PHARMACEUTICAL FORMULATIONS OF BIODEGRADABLE MICROPARTICLES HAVING IMPROVED RELEASE RATES

Country Status (7)

Country Link
EP (1) EP1931387A4 (en)
JP (1) JP2009507845A (en)
KR (1) KR20080059175A (en)
AU (1) AU2006287499A1 (en)
BR (1) BRPI0615563A2 (en)
CA (1) CA2621395A1 (en)
WO (1) WO2007030545A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2956345B1 (en) * 2010-02-17 2012-02-03 Ab7 Ind PROCESS FOR THE PREPARATION OF BIODEGRADABLE POLYMER GRANULES LOADED WITH ACTIVE LIPOPHILIC COMPOUNDS AND ACTIVE BIODEGRADABLE PRODUCTS OBTAINED
UA111162C2 (en) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. INJECTION COMPOSITION OF TRIAMCINOLONE ACETONIDE FOR TREATMENT OF PAIN
JP5926270B2 (en) 2010-10-26 2016-05-25 アルコン リサーチ, リミテッド Contact lens for ophthalmoscopic surgery
CA2843139C (en) * 2011-08-04 2019-09-24 Flexion Therapeutics, Inc. Corticosteroids for the treatment of joint pain
JP2015532928A (en) * 2012-09-20 2015-11-16 アキナ, インク.Akina, Inc. Biodegradable microcapsules containing filler material
EP3233056B1 (en) * 2014-12-15 2023-11-15 The Johns Hopkins University Sunitinib formulations and methods for use thereof in treatment of ocular disorders
JP7527562B2 (en) 2020-08-24 2024-08-05 学校法人福岡大学 Manufacturing method of microcapsules

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256677A (en) * 1976-04-12 1981-03-17 Magnavox Government And Industrial Electronics Co. Apparatus and method for making small spheres
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
WO2004041251A1 (en) * 2002-11-04 2004-05-21 Ocean Nutrition Canada Limited Microcapsules having multiple shells and method for the preparation thereof
WO2005018794A1 (en) * 2003-08-22 2005-03-03 Danisco A/S Microcapsules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675140A (en) * 1984-05-18 1987-06-23 Washington University Technology Associates Method for coating particles or liquid droplets
US5643594A (en) * 1992-05-29 1997-07-01 The Regents Of The University Of California Spin encapsulation apparatus and method of use
SE505146C2 (en) * 1995-10-19 1997-06-30 Biogram Ab Particles for delayed release
RU2005129278A (en) * 2003-02-20 2006-01-27 Алькон, Инк. (Ch) PREPARATORY GLUCOCORTICOIDS FOR THE TREATMENT OF PATHOLOGICAL EYE ANGIOGENESIS
JP4487141B2 (en) * 2003-08-20 2010-06-23 参天製薬株式会社 Drug delivery system for microtenon subcapsular administration
US7585517B2 (en) * 2003-09-18 2009-09-08 Macusight, Inc. Transscleral delivery
US8277831B2 (en) * 2004-02-17 2012-10-02 Advanced Technologies And Regenerative Medicine, Llc. Drug-enhanced adhesion prevention

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256677A (en) * 1976-04-12 1981-03-17 Magnavox Government And Industrial Electronics Co. Apparatus and method for making small spheres
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
WO2004041251A1 (en) * 2002-11-04 2004-05-21 Ocean Nutrition Canada Limited Microcapsules having multiple shells and method for the preparation thereof
WO2005018794A1 (en) * 2003-08-22 2005-03-03 Danisco A/S Microcapsules

Also Published As

Publication number Publication date
JP2009507845A (en) 2009-02-26
KR20080059175A (en) 2008-06-26
EP1931387A2 (en) 2008-06-18
WO2007030545A2 (en) 2007-03-15
BRPI0615563A2 (en) 2011-05-24
CA2621395A1 (en) 2007-03-15
AU2006287499A1 (en) 2007-03-15
WO2007030545A3 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
EP1931387A4 (en) PHARMACEUTICAL FORMULATIONS OF BIODEGRADABLE MICROPARTICLES HAVING IMPROVED RELEASE RATES
EP1895991A4 (en) Modified release formulations of anti-irritability drugs
EP1883406A4 (en) COMPOSITIONS AND METHODS FOR PROLONGED RELEASE OF BETA-ALANINE
HUE053838T2 (en) Sustained release formulations of nalbuphine
IL216401A0 (en) Sustained release of antinfectives
IL192990A0 (en) Methods and compositions of targeted drug development
ZA200807304B (en) Modified release formulations and methods of treating inflammatory bowel disease
SI2120585T1 (en) Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
PL2179098T3 (en) Toilet flusher having electromechanically induced release of active agent
HUE040391T2 (en) Slow release drug formulations made of microparticles
ZA200810178B (en) Pharmaceutical compositions for sustained release of phenyephrine
ZA200705533B (en) Sustained release composition of protein drug
FR2915683B1 (en) SELF-PRECIPITANT PHARMACEUTICAL FORMULATIONS FOR MODIFIED RELEASE OF ACTIVE INGREDIENTS
BRPI0615135A2 (en) drug compositions containing controlled release hypromellose matrices
EP2361907A4 (en) THE FIVE CRYSTALLINE FORMS OF NICOUSAMIDE, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
BRPI0906184A2 (en) method of preparing biodegradable microparticles containing medicaments
IL198170A0 (en) Robust sustained release formulations of oxymorphone and methods of use thereof
IL198169A0 (en) Robust sustained release formulations of oxymorphone
EP1931327A4 (en) CYCLOPROPYL COMPOUNDS AND COMPOSITIONS FOR RELEASING ACTIVE AGENTS
GB0722040D0 (en) Sustained release methotrexate formulations and methods of use thereof
EP1846037A4 (en) Methods of treating various conditions by administration of sustained release l-arginine
HK1120426A (en) Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates
BRPI0716344A2 (en) PHARMACEUTICAL COMPOSITION OF RELEASE TIME LATE COMBINATION

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080311

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZWIENER, ALBERT, M.

Inventor name: SLOVIN, ELIOT, M.

Inventor name: VAIL, NEAL, K.

Inventor name: MCDONOUGH, JOSEPH, A.

Inventor name: BARLOW, DARREN, E.

Inventor name: PERSYN, JOSEPH, T.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1120426

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20120613

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/00 20060101AFI20120606BHEP

Ipc: A61K 9/16 20060101ALI20120606BHEP

Ipc: A61K 47/32 20060101ALI20120606BHEP

Ipc: A61K 9/52 20060101ALI20120606BHEP

Ipc: A61K 9/00 20060101ALI20120606BHEP

Ipc: A61K 47/30 20060101ALI20120606BHEP

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130820

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140103

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1120426

Country of ref document: HK